Bioxytran Market Cap

Bioxytran has a market cap or net worth of $4.98 million as of March 6, 2026. Its market cap has decreased by -23.23% in one year.

Market Cap

4.98M

Enterprise Value

6.41M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.04

Market Cap Chart

Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 4.98M, a decrease of -80.49%. That is a compound annual growth rate of -19.69%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	4.98M	-38.91%
Dec 31, 2025	8.15M	4.49%
Dec 31, 2024	7.80M	-64.29%
Dec 29, 2023	21.85M	-63.00%
Dec 30, 2022	59.05M	33.18%
Dec 31, 2021	44.34M	89.57%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nymox Pharmaceutical	5.42M
Orgenesis	5.45M
Enzon Pharmaceuticals	4.50M
GPL Holdings	4.17M
AXIM Biotechnologies	3.99M
Mosaic ImmunoEngineering	3.77M
AccuStem Sciences	6.91M
Synlogic	7.01M

Market Cap Rankings